| ARROWHEAD PHARMACEUTICALS |
| USA |
| Gesundheit |
| US04280A1007 / A2AGYB |
| HDP1 (Frankfurt) / ARWR (NASDAQ) |
| FRA:HDP1, ETR:HDP1, HDP1:GR, NASDAQ:ARWR |
| - |
| https://arrowheadpharma.c.. |
|
Arrowhead Pharmaceuticals Inc. is a biotechnology ..
>Volltext.. |
| 8192.39 Mio. EUR |
| 8066.04 Mio. EUR |
| 706.5 Mio. EUR |
| 104.15 Mio. EUR |
| -1.39 Mio. EUR |
| -0.04 EUR |
| 624.93 Mio. EUR |
| 192.97 Mio. EUR |
| 152.94 Mio. EUR |
| 4.7 |
| 22063.21% |
| 99.74% |
| - |
| - |
| - |
| 3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 13.833.952 USD. |
| ARROWHEAD PHARMACEUTICALS, ARROWHEAD PHARMA, ARROWHEAD PHARMACEUTICAL |
| 16.12.25 |
|